Pricing Log in Create free account

Annexon, Inc. (ANNX) vs Solid Biosciences Inc. (SLDB)

Annexon, Inc. and Solid Biosciences Inc. are both Biotechnology companies. Annexon, Inc. and Solid Biosciences Inc. are of similar size ($848.2M and $794.3M). Across the 9 metrics below, Solid Biosciences Inc. leads on 9 and Annexon, Inc. on 0.

Valuation

Metric ANNX SLDB Biotechnology median
P/E n/m n/m 11.58
P/S n/m 101.91 9.61
P/B 5.99 3.35 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales n/m 70.86 9.43
Earnings yield (24.89%) (23.55%) (32.28%)
Free cash flow yield (22.16%) (17.47%) (22.27%)

Profitability

Metric ANNX SLDB Biotechnology median
Gross margin 0.00% 0.00% 68.81%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (130.80%) (76.87%) (50.30%)
Return on assets (82.98%) (64.86%) (45.47%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANNX SLDB Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) (32.67%) 34.97% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANNX SLDB Biotechnology median
Debt to equity 0.35 0.00 0.00
Current ratio 5.79 11.99 4.74
Net debt to EBITDA 1.11 1.05 1.01

Dividend

Metric ANNX SLDB Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ANNX SLDB Biotechnology median
Market cap 794.34m 848.24m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack